Close Close
Sign In
Newsletters
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
Podcast Center Video Center Webcasts Resource Center Events
About ThinkAdvisor Contact Us Advertise With Us Asset & Logo Licensing Sitemap Terms of Service Privacy Policy Copyright © 2024 ALM Global, LLC. All Rights Reserved.
ThinkAdvisor

Life Health > Health Insurance

CVS health narrows 2015 forecast as retail sales growth slows

By Ryan Sachetta

X
Your article was successfully shared with the contacts you provided.

(Bloomberg) — CVS Health Corp. (NYSE:CVS) narrowed its full-year earnings forecast after the pharmacy company’s retail sales growth slowed in the second quarter.

Adjusted profit will reach $5.11 to $5.18 a share, compared with a previous forecast of $5.08 to $5.19 a share, CVS said Tuesday. Analysts had projected $5.17 a share.

Retail sales rose 2.2 percent in the second quarter, the Woonsocket, R.I.-based company said in a statement. That compared with a 2.9 percent increase in the first three months of the year.

CVS shares fell 3 percent to $109.40 in early trading. The shares had gained 48 percent in the 12 months through Monday.

The new forecast overshadowed a second-quarter profit report that beat analysts’ estimates. Profit excluding one-time items was $1.22 a share, 2 cents above the average of analyst estimates compiled by Bloomberg. Sales rose 7.4 percent to $37.2 billion, in line with analysts’ estimates.

CVS, the largest provider of prescription drugs in the U.S., is expanding further beyond its retail roots with two second-quarter acquisitions. They’re part of a record year for the health care industry, with consolidation affecting insurers and drugmakers.

In May, CVS agreed to purchase nursing-home pharmacy Omnicare Inc. for $12.7 billion, expanding services to the country’s elderly. Less than four weeks later, CVS struck a deal to acquire Target Corp.’s pharmacies and clinics for $1.9 billion, putting its brand, which includes OneMinute Clinics, in retail locations across 47 states.

See also: CVS raising $15 billion in bond market to finance deals

Pharmacy services revenue rose 12 percent in the second quarter to $24.4 billion, the company said.

Front-of-store sales for locations that have been open at least a year dropped 7.8 percent, reflecting the company’s decision to stop selling tobacco products.

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.